PetMed Express names Christine Chambers CFO effective Aug 3, 2022; Rosenbloom departs

PETMED EXPRESS INC

Christine Chambers appointed CFO effective Aug 3, 2022; succeeds Bruce Rosenbloom who will transition out.
Chambers receives $375k base salary, $50k sign-on bonus (pro-rata clawback within 12 months).
Initial equity award: 13,000 restricted shares + 3,000 performance restricted shares, vesting over 3 years.
Severance: 12 months base salary + COBRA if terminated without cause.
Prior role: SVP, CFO & Treasurer at RealNetworks (RNWK); also held finance roles at Rosetta Stone.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christine Chambers

Chief Financial Officer

PETS · PETMED EXPRESS INC

Effective: 2022-08-03
Filed: July 14, 2022, 7:59 PM ET

On July 14, 2022, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Christine Chambers to serve as the Company’s Chief Financial Officer to assume the duties of principal financial officer and principal accounting officer effective August 3, 2022 (“Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Chambers was appointed as Chief Financial Officer at PETMED EXPRESS INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 14, 2022, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Christine Chambers to serve as the Company’s Chief Financial Officer to assume the duties of principal financial officer and principal accounting officer effective August 3, 2022 (“Effective Date”).

View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001437749-22-017145

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.